Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST®, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm.
Inhibits further breakdown of the aneurysm by disrupting the “aortic degradation process”.
Strengthens the...
Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST®, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm.
Inhibits further breakdown of the aneurysm by disrupting the “aortic degradation process”.
Strengthens the vessel wall by cross-linking within the tissue; this wall strengthening lowers the risk of rupture
Our technology allows for earlier intervention in a much safer manner
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.